Clinical Trial

The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.

Study acronym: HeartEpoch
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the feasibility and safety of polymer artificial heart valve designed and developed by Shanghai HeartEpoch Medical technology Co. Ltd. for the treatment of the mitral valve diseases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Status change: Not Yet Recruiting → Recruiting 2026-07-01
Trial Details
NCT Number NCT07243184
Lead Sponsor Shanghai HeartEpoch Medical Technology Co., Ltd
Conditions Severe Mitral Valve Regurgitation, Severe Mitral Valve Stenosis
Enrollment 10 participants
Start Date 2025-11-19
Primary Completion 2027-11 (estimated)
Study Completion 2032-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-06